Sign in / Join Now
ETFs & Funds
Broke through 50 day
and pivot point,
Indicator is at favorable +124, look to go long!
Add a reply...
Latest StockTalks »
people get BIIB breaking news and analysis by email alert.
Get email alerts on BIIB »
Get latest price
From other sites
The Ratings Game: Biogen gains on new Eli Lilly Alzheimer’s data, as beta-amyloid hypothesis ‘lives to see another day’
at MarketWatch.com (Fri, 12:55PM)
Jim Cramer -- Be Careful With Biogen; Apple Is Waking Up
at TheStreet (Fri, 10:41AM)
Attention Shifts to Biogen's Alzheimer's Drug in Wake of Lilly Results
at TheStreet (Fri, 10:39AM)
Biogen And AbbVie Receive Health Canada Approval Of Once-Monthly ZINBRYTA™ (Daclizumab Beta) For Multiple Sclerosis
at TheStreet (Fri, 8:00AM)
Biogen Presents Data From Phase 1b Study Of Investigational Alzheimer's Disease Treatment Aducanumab At 2016 Clinical Trials On Alzheimer's Disease Meeting
at TheStreet (Thu, 6:16PM)